©2018 by CardioScale Ltd.. Proudly created with Wix.com

June 17, 2018

CardioScale Wins The Combating Terrorism Technology StartUp Challange (CTTSC3) Presented by The US Department of Defence (CTTSO), Israel Department of Defence (MAFAT) and The MIT Enterprise Forum of Israel. 

May 18, 2017

CardioScale announced today that its Patent in Mainland China had successfully passed examination and was fully granted. The company specializing in early detection of hemodynamic deterioration based on its innovative technology announced that the Patent Office of chin...

April 15, 2017

The company specializing in early detection of hemodynamic deterioration based on its innovative technology announced today that the U.S. Patent and Trademark Office has granted its Reserve Index patent

May 9, 2016

Innovation in Emergency Medicine, Preparedness, Management & Rehabilitation.

Paris – France | 24 – 25 April, 2017

Sharing the best practices and technologies in the field of Medical Emergency, Medical Device & HealthCare IT companies in the various fields of emergency me...

May 9, 2016

Taiwan is a country with advanced medical technology, high-efficient infrastructure, and potential aging markets nearby. In 2016 Scientific AmericanWorldview: A Global Biotechnology Perspective, Taiwan’s business friendly environment, biotechnology venture capital avai...

May 9, 2016

We are delighted to inform that CardioScale's abstract has been selected by the Congress Scientific Committee to present its studies:  "The cardiovascular reserve index (CVRI) - a potential indicator of hemodynamic deterioration" at the Vienna Congress for intensive ca...

Please reload

Our Recent Posts

Please reload

Archive

Please reload

Tags

Please reload